Kyverna Therapeutics, Inc. Common Stock (KYTX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for KYTX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 116 institutions reported holding KYTX, with 37.6 million shares worth $335.0 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Gordonmd Global Investments | 4,244,818 | $38M | UNCHANGED |
| Gilead Sciences | 4,126,119 | $37M | UNCHANGED |
| BlackRock | 3,134,807 | $28M | INCREASED |
| Bain Capital Life Sciences Investors | 2,885,000 | $26M | DECREASED |
| Aigh Capital Management | 2,795,797 | $25M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Kyverna Therapeutics, Inc. Common Stock on SentiSense.